Nitric oxide: Considerations for the treatment of ischemic stroke

120Citations
Citations of this article
150Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Some 40 years ago it was recognized by Furchgott and colleagues that the endothelium releases a vasodilator, endothelium-derived relaxing factor (EDRF). Later on, several groups identified EDRF to be a gas, nitric oxide (NO). Since then, NO was identified as one of the most versatile and unique molecules in animal and human biology. Nitric oxide mediates a plethora of physiological functions, for example, maintenance of vascular tone and inflammation. Apart from these physiological functions, NO is also involved in the pathophysiology of various disorders, specifically those in which regulation of blood flow and inflammation has a key role. The aim of the current review is to summarize the role of NO in cerebral ischemia, the most common cause of stroke. © 2012 ISCBFM All rights reserved.

Cite

CITATION STYLE

APA

Terpolilli, N. A., Moskowitz, M. A., & Plesnila, N. (2012, July). Nitric oxide: Considerations for the treatment of ischemic stroke. Journal of Cerebral Blood Flow and Metabolism. https://doi.org/10.1038/jcbfm.2012.12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free